ClinicalTrials.gg
Not yet recruitingNCT07946055Updated Nov 18, 2026

Scapular Mobilization Added to Conventional Exercise in Ankylosing Spondylitis

An interventional study of Scapular Mobilization and Conventional Exercise Program in Ankylosing Spondylitis and Axial Spondyloarthritis, sponsored by Izmir Bakircay University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 30 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Izmir Bakircay University · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
30 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 84 studies in Spondylitis, Ankylosing with a site in Turkey — 19 open to participants now, 22 under way, none of them phase 3. Spondylitis, Ankylosing · Turkey.

Planned enrollment
42nd of 49
34 · median 60
Started
2026
with 8 others
No phase
37 of 84
12 open now
Primary completion
2027-11
later than 20 of 21 live
Registered
84th of 84
by date

Among the 84 studies in Spondylitis, Ankylosing with a site in Turkey, this one is the 42nd largest by planned enrollment of the 49 interventional ones that give a count, is one of 9 that started in 2026, is one of 37 with no phase, reaches primary completion later than 20 of the 21 other live ones, and was the 84th registered.

Spondylitis, Ankylosing

533 studies on the registry are indexed under Spondylitis, Ankylosing; 98 are open to participants now.

Browse Spondylitis, Ankylosing studies →

Open to participants now

19 of the 84 studies in Spondylitis, Ankylosing with a site in Turkey are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 62 Spondylitis, Ankylosing studies recruiting now, 24 (39%) set no upper age limit and 32 (52%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 30 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 84 studies in Spondylitis, Ankylosing with a site in Turkey, or all of them as a file.
02

Study summary

Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial skeleton that commonly leads to restricted spinal mobility, postural deformities such as thoracic hyperkyphosis, and reduced chest wall expansion, which can impair respiratory function and quality of life. Exercise is the cornerstone of rehabilitation in AS, and manual therapy techniques may provide additional benefit by restoring mobility of the thoracic cage and shoulder girdle.

The aim of this randomized controlled, single-blind trial is to investigate whether scapular mobilization added to a conventional exercise program improves chest expansion and respiratory function (primary outcomes), as well as pain, disease activity, function, spinal mobility, posture, exercise capacity, and quality of life (secondary outcomes) in patients with AS. Thirty-four patients will be randomly allocated to either scapular mobilization plus conventional exercise or conventional exercise alone, 3 sessions per week for 8 weeks (24 sessions). Outcomes will be assessed at baseline, after treatment (week 8), and at month 3.

Read the detailed description

Background: AS is a chronic inflammatory disease most frequently seen in young men, involving the spine, sacroiliac joints, peripheral joints, and entheses, and causing pain, stiffness, functional impairment, and postural abnormalities. Dysfunction of the thoracic spine and scapular region not only causes pain and limited movement but also restricts chest wall mobility, which may reduce ventilatory efficiency and quality of life. Previous studies have shown that thoracic mobilization exercises improve kyphosis and respiratory function (FVC, FEV1), aerobic exercise improves disease activity and respiratory muscle strength, and manual therapy added to exercise provides superior improvements in chest expansion and functional capacity. However, evidence on the specific added contribution of scapular mobilization to standard exercise programs is limited.

Design: Prospective, randomized, controlled, single-blind, parallel-group trial conducted at the Physical Medicine and Rehabilitation outpatient clinic of Izmir Bakircay University Cigli Training and Research Hospital.

Sample size: Based on Acharya et al. (2024), with an effect size of Cohen's d = 0.40, alpha = 0.05, power = 80%, a two-group repeated-measures design with three time points and a correlation of 0.3 between repeated measures, the minimum sample size is 30 (15 per group). Allowing for a 10% dropout rate, 34 participants (17 per group) will be enrolled.

Interventions: Both groups will receive the same progressive conventional exercise program (30 minutes per session, 3 sessions/week, 8 weeks, 24 sessions), supervised by the same physiotherapist. The experimental group will additionally receive approximately 20 minutes of scapular mobilization per session.

Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Progression: Weeks 1-2 (initial level: movement learning, low-intensity mobility, breathing, stretching and low-resistance strengthening; 8-10 repetitions, 1-2 sets, slow tempo); weeks 3-5 (intermediate: increased repetitions and sets, dynamic movements, moderate elastic band resistance, breathing combined with arm movements; 10-15 repetitions, 2-3 sets, moderate tempo); weeks 6-8 (advanced: higher resistance, multi-joint functional movements, dynamic balance and coordination, increased aerobic duration; 12-15 repetitions, 3 sets, moderate-to-high tempo). Progression requires correct form, no increase in pain (VAS) during exercise, return of symptoms to baseline within 24 hours, and improved functional performance. Regression to the previous level occurs with increased pain, prolonged fatigue, postural deterioration, or compensatory movement patterns.

Scapular mobilization: Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Assessments: Demographic and clinical data (age, sex, height, weight, education, occupation, smoking/alcohol, family history, diagnosis year, symptom duration, medications and duration of use, extra-articular involvement, previous surgery, exercise habits) will be recorded. Outcome measures (VAS, BASDAI, BASFI, BASMI, ASQoL, chest expansion, spirometry, 6-minute walk test, thoracic kyphosis angle by digital inclinometer) will be assessed at baseline, after treatment (week 8), and at month 3.

Hypotheses: H0 - Scapular mobilization added to routine exercises has no effect on pain, posture, respiratory function, and quality of life in patients with AS. H1 - Scapular mobilization added to routine exercises has an effect on these parameters.

Statistical analysis: SPSS version 20.0 will be used, with p \< 0.05 considered significant. Normality will be tested with the Kolmogorov-Smirnov test. Repeated-measures ANOVA will be used for parametric data; Friedman and Wilcoxon signed-rank tests for non-parametric data. Categorical variables will be compared using the chi-square test.

03

Conditions studied

  • Ankylosing Spondylitis
  • Axial Spondyloarthritis

Keywords

  • Ankylosing spondylitis
  • Scapular mobilization
  • Manual therapy
  • Exercise therapy
  • Respiratory function
  • Chest expansion
  • Posture
  • Thoracic kyphosis
  • Quality of life
  • Rehabilitation
04

Who can participate

Ages eligible
30 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of ankylosing spondylitis according to the modified New York criteria
  • Age between 30 and 60 years
  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score of 4.0 or lower
  • Pulmonary function test performed within the last month

Exclusion criteria

Exclusion Criteria:

  • Regular exercise during the previous 3 months
  • Spinal ankylosis
  • Cardiovascular, pulmonary, orthopedic, or neurological conditions that may prevent exercise (uncontrolled hypertension, history of myocardial infarction or coronary revascularization, history of syncope or exercise-related arrhythmia, decompensated type 1 diabetes mellitus, history of hip and/or knee arthroplasty)
  • Any surgery within the last 6 months
  • Active disease flare within the last 3 months
  • Communication problems
  • Any other respiratory or neuromuscular disease that may affect the respiratory muscles
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Scapular Mobilization + Conventional Exercise

    Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

    Other: Scapular Mobilization · Other: Conventional Exercise Program

  • Active comparator
    Conventional Exercise

    Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

    Other: Conventional Exercise Program

Interventions

  • OtherScapular Mobilization

    Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

    Also known as: Maitland scapular mobilization

  • OtherConventional Exercise Program

    posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

    Also known as: Standard exercise therapy

06

What researchers measure

Primary outcomes

  1. Chest Expansion

    Time frame: Baseline, week 8 (end of treatment), and month 3

  2. Forced Vital Capacity (FVC)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  3. Forced Expiratory Volume in 1 Second (FEV1)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  4. FEV1/FVC Ratio

    Time frame: Baseline, week 8 (end of treatment), and month 3

Secondary outcomes

  1. Peak Expiratory Flow (PEF)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  2. Thoracic Pain Intensity (Visual Analog Scale)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  3. Disease Activity (BASDAI)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  4. Functional Status (BASFI)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  5. Spinal Mobility (BASMI)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  6. Quality of Life (ASQoL)

    Time frame: Baseline, week 8 (end of treatment), and month 3

  7. Thoracic Kyphosis Angle

    Time frame: Baseline, week 8 (end of treatment), and month 3

  8. Functional Exercise Capacity (6-Minute Walk Test)

    Time frame: Baseline, week 8 (end of treatment), and month 3

07

Study locations

1 site
08

References and documents

Publications

  • Basakci Calik B, Pekesen Kurtca M, Gur Kabul E, Telli Atalay O, Taskin H, Yigit M, Tasci M, Cobankara V. Investigation of the effectiveness of aerobic exercise training in individuals with ankylosing spondylitis: Randomized controlled study. Mod Rheumatol. 2021 Mar;31(2):442-450. doi: 10.1080/14397595.2020.1745409. Epub 2020 Apr 14. PubMed 32202181 ↗
  • Solak O, Atalay NS, Genç H, et al. The effect of thoracic mobilization exercises on respiratory function and spinal mobility in ankylosing spondylitis. Physiother Theory Pract. 2017;33(10):769-777.
  • Acharya NN, Venkatesan P, Karvannan H, Balebail Gopalakrishna D. Comparison of Yoga with exercise in ankylosing spondylitis on mobility and functional capacity. Int J Rheum Dis. 2024 Jun;27(6):e15223. doi: 10.1111/1756-185X.15223. PubMed 38873950 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data will not be made publicly available but can be shared with qualified researchers upon reasonable request to the principal investigator.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

Of 61 non-industry interventional studies with no phase under Spondylitis, Ankylosing, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 20. This study's planned 12 months is close to that.

Counting every sponsor, half of 64 studies reached it within 12 months; a quarter within 7 and three quarters within 20.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 18, 2026
StartEst.
Nov 16, 2026
Primary completionEst.
Nov 16, 2027
CompletionEst.
Nov 25, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946055
Lead sponsor
Izmir Bakircay University
Responsible party
Elif Umay Altas (Prof, Izmir Bakircay University) — Principal investigator
First posted
Nov 18, 2026
Start date
Nov 16, 2026 (estimated)
Primary completion
Nov 16, 2027 (estimated)
Completion
Nov 25, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Elif Umay Altaş
principal investigator · Izmir Bakircay University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion